Galmed Pharmaceuticals Ltd (GLMD) Annual Balance Sheets

Annual · GAAP · USD millions
Access GLMD quarterly Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Galmed Pharmaceuticals Ltd balances growth, leverage, and shareholder equity.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent3.99
Marketable Securities, Current SH7.33
Deposits Assets, Current AS7.15
Cash & Short-term Investments17.00
Accounts receivable0.00
Other Receivables, Net, Current0.35
Other Current Assets0.12
Total loans net0.27
Total Current Assets18.63
Equipment/Property/Plant Net0.00
Long-term investments0.00
Tax Assets, Noncurrent205.90
Other Assets, Noncurrent0.00
Restricted Cash Current0.12
Operating Lease Right Of Use Asset-
Total Assets18.63
Liabilities
Accounts Payable, Current AC2.00
Accrued Liabilities, Current0.28
Other Loans Payable, Current OT0.84
Total Current Liabilities2.85
Long-term debt0.00
Total Long-term Debt0.00
Operating Lease Liability Noncurrent-
Total Liabilities2.85
Stockholders' Equity
Common Stock Value3.41
Additional Paid In Capital Common Stock223.46
Retained Earnings / Accumulated Deficit-210.78
Accumulated Other Comprehensive Income-0.30
Other Equity-0.30
Common Stockholder's Equity15.78
Total Stockholder's Equity15.78
Liabilities & Stockholder's Equity18.63
4 historic quarters locked

Sign in to unlock the full Galmed Pharmaceuticals Ltd balance sheet history.

About Galmed Pharmaceuticals Ltd Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: March 31, 2026
  • Source: form20-f.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-014182

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.